MLTX MoonLake Immunotherapeutics
Healthcare$18.32+0.00%OpenMarket Cap: $1.35B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$28.50
Target (Median)
$29.50
Target Range
$10.00 - $45.00
Upside from current price: 55.6%
Rating Distribution
1 Strong Buy11 Buy2 Hold2 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-12 | Needham | maintain | Buy | Buy |
| 2026-05-11 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-30 | BTIG | maintain | Buy | Buy |
| 2026-03-23 | Wolfe Research | upgrade | Outperform | Underperform |
| 2026-03-19 | Rothschild & Co | upgrade | Buy | Neutral |
| 2026-03-11 | Clear Street | maintain | Buy | Buy |
| 2026-03-02 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-03-02 | RBC Capital | maintain | Sector Perform | Sector Perform |
| 2026-02-26 | Needham | maintain | Buy | Buy |
| 2026-02-24 | Oppenheimer | maintain | Outperform | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-3.64 | $22.8M | 8 |
| Sun Dec 31 | $-2.90 | $135.7M | 7 |
| Mon Dec 31 | $-0.83 | $443.1M | 2 |
| Tue Dec 31 | $2.09 | $817.5M | 5 |